Home Aminos 4-((4-(4-Chlorophenyl)thiazol-2-yl)amino)phenol

4-((4-(4-Chlorophenyl)thiazol-2-yl)amino)phenol

CAS No.:
312636-16-1
Catalog Number:
AG0037DR
Molecular Formula:
C15H11ClN2OS
Molecular Weight:
302.7786
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
10mg
99%
1 week
United States
$157
- +
25mg
99%
1 week
United States
$257
- +
50mg
99%
1 week
United States
$407
- +
100mg
99%
1 week
United States
$707
- +
200mg
99%
1 week
United States
$1223
- +
Product Description
Catalog Number:
AG0037DR
Chemical Name:
4-((4-(4-Chlorophenyl)thiazol-2-yl)amino)phenol
CAS Number:
312636-16-1
Molecular Formula:
C15H11ClN2OS
Molecular Weight:
302.7786
MDL Number:
MFCD00733553
IUPAC Name:
4-[[4-(4-chlorophenyl)-1,3-thiazol-2-yl]amino]phenol
InChI:
InChI=1S/C15H11ClN2OS/c16-11-3-1-10(2-4-11)14-9-20-15(18-14)17-12-5-7-13(19)8-6-12/h1-9,19H,(H,17,18)
InChI Key:
ZFGXZJKLOFCECI-UHFFFAOYSA-N
SMILES:
Oc1ccc(cc1)Nc1scc(n1)c1ccc(cc1)Cl
Properties
Complexity:
304  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
302.028g/mol
Formal Charge:
0
Heavy Atom Count:
20  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
302.776g/mol
Monoisotopic Mass:
302.028g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
73.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.8  
Literature
Title Journal
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery. The Biochemical journal 20130415
Inhibition kinetics and regulation of sphingosine kinase 1 expression in prostate cancer cells: functional differences between sphingosine kinase 1a and 1b. The international journal of biochemistry & cell biology 20120901
Inhibition of sphingosine kinase 1 enhances cytotoxicity, ceramide levels and ROS formation in liver cancer cells treated with selenite. Biochemical pharmacology 20120901
Sphingosine kinase isoforms as a therapeutic target in endocrine therapy resistant luminal and basal-A breast cancer. Experimental biology and medicine (Maywood, N.J.) 20120701
Dual inhibition of sphingosine kinase isoforms ablates TNF-induced drug resistance. Oncology reports 20120601
Increasing ceramides sensitizes genistein-induced melanoma cell apoptosis and growth inhibition. Biochemical and biophysical research communications 20120511
Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer. British journal of cancer 20120410
Targeting sphingosine kinase-1 to inhibit melanoma. Pigment cell & melanoma research 20120301
Reversion of multidrug resistance by SKI-II in SGC7901/DDP cells and exploration of underlying mechanisms. Asian Pacific journal of cancer prevention : APJCP 20120101
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nature biotechnology 20111101
Sphingosine induces apoptosis in hippocampal neurons and astrocytes by activating caspase-3/-9 via a mitochondrial pathway linked to SDK/14-3-3 protein/Bax/cytochrome c. Journal of cellular physiology 20110901
Endogenous sphingosine 1-phosphate regulates spontaneous glutamate release from mossy fiber terminals via S1P(3) receptors. Life sciences 20110718
Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer. Journal of molecular endocrinology 20110601
Photolysis of caged sphingosine-1-phosphate induces barrier enhancement and intracellular activation of lung endothelial cell signaling pathways. American journal of physiology. Lung cellular and molecular physiology 20110601
Determination of sphingosine kinase 2 activity using fluorescent sphingosine by capillary electrophoresis. Electrophoresis 20110601
Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells. Journal of medicinal chemistry 20110526
Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition. Head & neck 20110201
High-throughput screening assay for sphingosine kinase inhibitors in whole blood using RapidFire® mass spectrometry. Journal of biomolecular screening 20110201
Intracellular S1P generation is essential for S1P-induced motility of human lung endothelial cells: role of sphingosine kinase 1 and S1P lyase. PloS one 20110101
Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells. PloS one 20110101
Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions. PloS one 20110101
Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells. BMC cancer 20110101
Vessel-specific role of sphingosine kinase 1 in the vasoconstriction of isolated basilar arteries. Pharmacological research 20101201
Synthesis and bioactivity of sphingosine kinase inhibitors and their novel aspirinyl conjugated analogs. European journal of medicinal chemistry 20100901
Sphingosine kinase inhibition alleviates endothelial permeability induced by thrombin and activated neutrophils. Shock (Augusta, Ga.) 20100401
Isoflurane protects human kidney proximal tubule cells against necrosis via sphingosine kinase and sphingosine-1-phosphate generation. American journal of nephrology 20100401
2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97). Bioorganic & medicinal chemistry letters 20100301
A novel mode of action of the putative sphingosine kinase inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl) thiazole (SKI II): induction of lysosomal sphingosine kinase 1 degradation. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20100101
SKI-II, an inhibitor of sphingosine kinase, ameliorates antigen-induced bronchial smooth muscle hyperresponsiveness, but not airway inflammation, in mice. Journal of pharmacological sciences 20100101
A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cells. Cancer chemotherapy and pharmacology 20091001
Role of sphingosine-1-phosphate (S1P) and the S1P(2) receptor in allergen-induced, mast cell-dependent contraction of rat lung parenchymal strips. Naunyn-Schmiedeberg's archives of pharmacology 20091001
Sphingosine kinase 1 is essential for proteinase-activated receptor-1 signalling in epithelial and endothelial cells. The international journal of biochemistry & cell biology 20090701
In vitro anti-leukaemia activity of sphingosine kinase inhibitor. British journal of haematology 20090201
Calcium entry inhibition during resuscitation from shock attenuates inflammatory lung injury. Shock (Augusta, Ga.) 20080701
Inhalation of sphingosine kinase inhibitor attenuates airway inflammation in asthmatic mouse model. American journal of physiology. Lung cellular and molecular physiology 20080601
Activation of sphingosine kinase-1 mediates induction of endothelial cell proliferation and angiogenesis by epoxyeicosatrienoic acids. Cardiovascular research 20080501
Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells. The Prostate 20071101
Disruption of retinoic acid receptor alpha reveals the growth promoter face of retinoic acid. PloS one 20070101
Pharmacologic manipulation of sphingosine kinase in retinal endothelial cells: implications for angiogenic ocular diseases. Investigative ophthalmology & visual science 20061101
Sphingosine kinase regulates voltage operated calcium channels in GH4C1 rat pituitary cells. Cellular signalling 20060901
Antitumor activity of sphingosine kinase inhibitors. The Journal of pharmacology and experimental therapeutics 20060801
Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer research 20030915
Human sphingosine kinase: purification, molecular cloning and characterization of the native and recombinant enzymes. The Biochemical journal 20000901
Properties